MNB/DYRK1A as a multiple regulator of neuronal development

FEBS Journal

Volumn 278, Issue 2, 2011, Pages 223-235

  Tejedor, Francisco J ^a   Hämmerle, Barbara ^b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

Down syndrome; neural proliferation; neurogenesis; neuronal differentiation; protein kinase

Indexed keywords

CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3; MEMBRANE PROTEIN; PROTEIN DYRK1A; PROTEIN MNB; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; BRAIN DEVELOPMENT; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DOPAMINERGIC TRANSMISSION; DROSOPHILA; ENDOCYTOSIS; ENZYME ACTIVITY; HUMAN; MOLECULAR DYNAMICS; MORPHOGENESIS; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TELENCEPHALON; TRANSCRIPTION REGULATION;

ANIMALS; DOWN SYNDROME; HUMANS; NEUROGENESIS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES;

EID: 78651062069     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07954.x     Document Type: Review

References (99)

1. Galceran J, de Graaf K, Tejedor FJ, &, Becker W, (2003) The MNB/DYRK1A protein kinase: genetic and biochemical properties. J Neural Transm Suppl 67, 139-148.
2. Becker W, &, Sippl W, (2010) Activation, regulation, and inhibition of the protein kinase DYRK1A. FEBS J 277.
3. Guimerá J, Casas C, PucharcÃs C, Solans A, DomÃnech A, Planas AM, Ashley J, Lovett M, Estivill X, &, Pritchard MA, (1996) A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet 5, 1305-1310.
4. Song WJ, Sternberg LR, Kasten-Sportes C, Keuren ML, Chung SH, Slack AC, Miller DE, Glover TW, Chiang PW, Lou L, et al. (1996) Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region". Genomics 38, 331-339.
5. Guimerá J, Casas C, Estivill X, &, Pritchard M, (1999) Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 57, 407-418.
6. Hämmerle B, Elizalde C, Galceran J, Becker W, &, Tejedor FJ, (2003) The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications. J Neural Transm Suppl 67, 129-137.
7. Dierssen M, &, de Lagrán MM., (2006) DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis. Sci World J 6, 1911-1922.
8. Dowjat WK, Adayev T, Kuchna I, Nowicki K, Palminiello S, Hwang YW, &, Wegiel J, (2007) Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci Lett 413, 77-81.
9. Wegiel J, Gong C-X, &, Hwang Y-W, (2010) DYRK1A: the role in neurodegenerative diseases. FEBS J 277.
10. Tejedor F, Zhu XR, Kaltenbach E, Ackermann A, Baumann A, Canal I, Heisenberg M, Fischbach KF, &, Pongs O, (1995) minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron 14, 287-301.
11. Fotaki V, Dierssen M, Alcantara S, Martinez S, Marti E, Casas C, Visa J, Soriano E, Estivill X, &, Arbones ML, (2002) Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 22, 6636-6647.
12. Moeller RS, Kübart S, Hoeltzenbein M, Heye B, Vogel I, Hansen CP, Menzel C, Ullmann R, Tommerup N, Ropers HH, et al. (2008) Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am J Hum Genet 82, 1165-1170.
13. Okui M, Ide T, Morita K, Funakoshi E, Ito F, Ogita K, Yoneda Y, Kudoh J, &, Shimizu N, (1999) High-level expression of the Mnb/Dyrk1A gene in brain and heart during rat early development. Genomics 62, 165-171.
14. Hämmerle B, Elizalde C, &, Tejedor FJ, (2008) The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development. Eur J Neurosci 27, 1061-1074.
15. Hämmerle B, Vera-Samper E, Speicher S, Arencibia R, Martinez S, &, Tejedor FJ, (2002) Mnb/Dyrk1A is transiently expressed and asymmetrically segregated in neural progenitor cells at the transition to neurogenic divisions. Dev Biol 246, 259-273.
16. Hämmerle B, Carnicero A, Elizalde C, Ceron J, Martínez S, &, Tejedor FJ, (2003) Expression patterns and subcellular localization of the Down syndrome candidate protein MNB/DYRK1A suggest a role in late neuronal differentiation. Eur J Neurosci 17, 2277-2286.
17. Marti E, Altafaj X, Dierssen M, de la Luna S, Fotaki V, Alvarez M, Perez-Riba M, Ferrer I, &, Estivill X, (2003) Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res 964, 250-263.
18. Iacopetti P, Michelini M, Stuckmann I, Oback B, Aaku-Saraste E, &, Huttner WB, (1999) Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division. Proc Natl Acad Sci USA 96, 4639-4644.
19. Ferron SR, Pozo N, Laguna A, Aranda S, Porlan E, Moreno M, Fillat C, de la Luna S, Sánchez P, Arbonés ML, et al. (2010) Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling. Cell Stem Cell 7 (3), 367-379.
20. Bähler J, &, Nurse P, (2001) Fission yeast Pom1p kinase activity is cell cycle regulated and essential for cellular symmetry during growth and division. EMBO J 20, 1064-1073.
21. Raich WB, Moorman C, Lacefield CO, Lehrer J, Bartsch D, Plasterk RH, Kandel ER, &, Hobert O, (2003) Characterization of Caenorhabditis elegans homologs of the Down syndrome candidate gene DYRK1A. Genetics 163, 571-580.
22. Maenz B, Hekerman P, Vela EM, Galceran J, &, Becker W, (2008) Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1. BMC Mol Biol 26, 9.
23. Kinstrie R, Lochhead A, Sibbet G, Morrice N, &, Cleghon V, (2006) dDYRK2 and Minibrain interact with the chromatin remodelling factors SNR1 and TRX. Biochem J 398, 45-54.
24. Zraly CB, Marenda DR, &, Dingwall AK, (2004) SNR1 (INI1/SNF5) mediates important cell growth functions of the Drosophila Brahma (SWI/SNF) chromatin remodeling complex. Genetics 168, 199-214.
25. Branchi I, Bichler Z, Minghetti L, Delabar JM, Malchiodi-Albedi F, Gonzalez MC, Chettouh Z, Nicolini A, Chabert C, Smith DJ, et al. (2004) Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration. J Neuropathol Exp Neurol 63, 429-440.
26. Yabut O, Domogauer J, &, D'Arcangelo G, (2010) Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells. J Neurosci 30, 4004-4014.
27. Park J, Oh Y, Yoo L, Jung MS, Song WJ, Lee SH, Seo H, &, Chung KC, (2010) DYRK1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells. J Biol Chem 285, 31895-31906.
28. Funakoshi E, Hori T, Haraguchi T, Hiraoka Y, Kudoh J, Shimizu N, &, Ito F, (2003) Overexpression of the human MNB/DYRK1A gene induces formation of multinucleate cells through overduplication of the centrosome. BMC Cell Biol 4, 12.
29. Nguyen L, Besson A, Roberts JM, &, Guillemot F, (2006) Coupling cell cycle exit, neuronal differentiation and migration in cortical neurogenesis. Cell Cycle 20, 2314-2318.
30. Ewton DZ, Lee K, Deng X, Lim S, &, Friedman E, (2003) Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants. Int J Cancer 103, 21-28.
31. Fernandez-Martinez J, Vela EM, Tora-Ponsioen M, Ocaña OH, Nieto MA, &, Galceran J, (2009) Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. J Cell Sci 122, 1574-1583.
32. Louvi A, &, Artavanis-Tsakonas S, (2006) Notch signalling in vertebrate neural development. Nat Rev Neurosci 7, 93-102.
33. Canzonetta C, Mulligan C, Deutsch S, Ruf S, O'Doherty A, Lyle R, Borel C, Lin-Marq N, Delom F, Groet J, et al. (2008) DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet 83, 388-400.
34. Chong JA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, Boutros MC, Altshuller YM, Frohman MA, Kraner SD, &, Mandel G, (1995) REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80, 949-957.
35. Ballas N, Grunseich C, Lu DD, Speh JC, &, Mandel G, (2005) REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121, 645-657.
36. Mao J, Maye P, Kogerman P, Tejedor FJ, Toftgard R, Xie W, Wu G, &, Wu D, (2002) Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J Biol Chem 277, 35156-35161.
37. Ruiz i Altaba A, Palma V, &, Dahmane N, (2002) Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci 3, 24-33.
38. Yang EJ, Ahn YS, &, Chung KC, (2001) Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells. J Biol Chem 276, 39819-39824.
39. Kelly PA, &, Rahmani Z, (2005) DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1. Mol Biol Cell 16, 3562-3573.
40. Göckler N, Jofre G, Papadopoulos C, Soppa U, Tejedor FJ, &, Becker W, (2009) Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. FEBS J 276, 6324-6337.
41. Benavides-Piccione R, Dierssen M, Ballesteros-Yáñez I, Martínez de Lagrán M, Arbonés ML, Fotaki V, DeFelipe J, &, Elston GN, (2005) Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/-mouse. Neurobiol Dis 20, 115-122.
42. Liu T, Sims D, &, Baum B, (2009) Parallel RNAi screens across different cell lines identify generic and cell type-specific regulators of actin organization and cell morphology. Genome Biol 10, R26.
43. Scales TM, Lin S, Kraus M, Goold RG, &, Gordon-Weeks PR, (2009) Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons. J Cell Sci, 122, 2424-2435.
44. Parrish JZ, Kim MD, Jan LY, &, Jan YN, (2006) Genome-wide analyses identify transcription factors required for proper morphogenesis of Drosophila sensory neuron dendrites. Genes Dev 20, 820-835.
45. Lepagnol-Bestel AM, Zvara A, Maussion G, Quignon F, Ngimbous B, Ramoz N, Imbeaud S, Loe-Mie Y, Benihoud K, Agier N, et al. (2009) DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. Hum Mol Genet 18, 1405-1414.
46. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, et al. (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441, 595-600.
47. Gwack Y, Sharma S, Nardone J, Tanasa B, Iuga A, Srikanth S, Okamura H, Bolton D, Feske S, Hogan PG, et al. (2006) A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441, 646-650.
48. Graef IA, Wang F, Charron F, Chen L, Neilson J, Tessier-Lavigne M, &, Crabtree GR, (2003) Neurotrophins and netrins require calcineurin/NFAT signalling to stimulate outgrowth of embryonic axons. Cell 113, 657-670.
49. Sitz JH, Baumgärtel K, Hämmerle B, Papadopoulos C, Hekerman P, Tejedor FJ, Becker W, &, Lutz B, (2008) The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4. Neuroscience 157, 596-605.
50. Chen-Hwang MC, Chen HR, Elzinga M, &, Hwang YW, (2002) Dynamin is a minibrain kinase/dual specificity Yak1-related kinase 1A substrate. J Biol Chem 277, 17597-17604.
51. Huang Y, Chen-Hwang MC, Dolios G, Murakami N, Padovan NC, Wang R, &, Hwang YW, (2004) Mnb/Dyrk1A phosphorylation regulates the interaction of dynamin 1 with SH3 domain-containing proteins. Biochemistry 43, 10173-10185.
52. Kinoshita A, Kinoshita M, Akiyama H, Tomimoto H, Akiguchi I, Kumar S, Noda M, &, Kimura J, (1998) Identification of septins in neurofibrillary tangles in Alzheimer's disease. Am J Pathol 153, 1551-1560.
53. Adayev T, Chen-Hwang MC, Murakami N, Wang R, &, Hwang YW, (2006) MNB/DYRK1A phosphorylation regulates the interactions of synaptojanin 1 with endocytic accessory proteins. Biochem Biophys Res Commun 351, 1060-1065.
54. Murakami N, Xie W, Lu RC, Chen-Hwang MC, Wieraszko A, &, Hwang YW, (2006) Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome. J Biol Chem 281, 23712-23724.
55. Murakami N, Bolton D, &, Hwang YW, (2009) Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles. Biochemistry 48, 9297-9305.
56. Ahn KJ, Jeong HK, Choi HS, Ryoo SR, Kim YJ, Goo JS, Choi SY, Han JS, Ha I, &, Song WJ, (2006) DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol Dis 22, 463-472.
57. Martinez de Lagran M, Bortolozzi A, Millan O, Gispert JD, Gonzalez JR, Arbones ML, Artigas F, &, Dierssen M, (2007) Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-). Genes Brain Behav 6, 569-578.
58. Cline HT, (2001) Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol 11, 118-126.
59. Laguna A, Aranda S, Barallobre MJ, Barhoum R, Fernández E, Fotaki V, Delabar JM, de la Luna S, de la Villa P, &, Arbonés ML, (2008) The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. Dev Cell 15, 841-853.
60. Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, Noel B, &, Sinet PM, (1993) Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet 1, 114-124.
61. Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, Grubert F, Erdman C, Gao MC, Lange K, et al. (2009) The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci USA 106, 12031-12036.
62. Coyle JT, Oster-Granite ML, &, Gearhart JD, (1986) The neurobiologic consequences of Down syndrome. Brain Res Bull 16, 773-787.
63. Wisniewski KE, Laure-Kamionowska M, &, Wisniewski HM, (1984) Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome. N Engl J Med 311, 1187-1188.
64. Schmidt-Sidor B, Wisniewski KE, Shepard TH, &, Sersen EA, (1990) Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 9, 181-190.
65. Chakrabarti L, Galdzicki Z, &, Haydar TF, (2007) Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci 27, 11483-11495.
66. Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, &, Ciani E, (2007) Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17, 665-678.
67. Guidi S, Bonasoni P, Ceccarelli C, Santini D, Gualtieri F, Ciani E, &, Bartesaghi R, (2008) Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol 18, 180-197.
68. Calegari F, Haubensak W, Haffner C, &, Huttner WB, (2005) Selective lengthening of the cell cycle in the neurogenic subpopulation of neural progenitor cells during mouse brain development. J Neurosci 25, 6533-6538.
69. Smith DJ, Stevens ME, Sudanagunta SP, Bronson RT, Makhinson M, Watabe AM, O'Dell TJ, Fung J, Weier HU, Cheng JF, et al. (1997) Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet 16, 28-36.
70. Altafaj X, Dierssen M, Baamonde C, Martí E, Visa J, Guimerà J, Oset M, González JR, Flõrez J, Fillat C, et al. (2001) Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum Mol Genet 10, 1915-1923.
71. Kaufmann WE, &, Moser HW, (2000) Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 10, 981-991.
72. Busciglio J, &, Yankner BA, (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378, 776-779. (Pubitemid 26004408)
73. Chang HS, Lin CH, Yang CH, Yen MS, Lai CR, Chen YR, Liang YJ, &, Yu WC, (2007) Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis. Int J Cancer 120, 2377-2385.
74. Guo X, Williams JG, Schug TT, &, Li X, (2010) DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J Biol Chem 285, 13223-13232.
75. Becker W, Weber Y, Wetzel K, Eirmbter K, Tejedor FJ, &, Joost HG, (1998) Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 273, 25893-25902.
76. Park J, Yang EJ, Yoon JH, &, Chung KC, (2007) Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome. Mol Cell Neurosci 36, 270-279.
77. Lochhead PA, Sibbet G, Morrice N, &, Cleghon V, (2005) Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 121, 925-936.
78. Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Yamagata H, et al. (2007) The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 16, 15-23.
79. Sitz JH, Tigges M, Baumgärtel K, Khaspekov LG, &, Lutz B, (2004) Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4. Mol Cell Biol 24, 5821-5834.
80. Ryoo SR, Cho HJ, Lee HW, Jeong HK, Radnaabazar C, Kim YS, Kim MJ, Son MY, Seo H, Chung SH, et al. (2008) Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. J Neurochem 104, 1333-1344.
81. Shi J, Zhang T, Zhou C, Chohan MO, Gu X, Wegiel J, Zhou J, Hwang YW, Iqbal K, Grundke-Iqbal I, et al. (2008) Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome. J Biol Chem 283, 28660-28669.
82. Seifert A, Allan LA, &, Clarke PR, (2008) DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine. FEBS J 275, 6268-6280.
83. Seifert A, &, Clarke PR, (2009) p38α-and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress. Cell Signal 21, 1626-1633.
84. Kurabayashi N, Hirota T, Sakai M, Sanada K, &, Fukada Y, (2010) DYRK1A and glycogen synthase kinase 3beta, a dual-kinase mechanism directing proteasomal degradation of CRY2 for circadian timekeeping. Mol Cell Biol 30, 1757-1768.
85. Woods YL, Rena G, Morrice N, Barthel A, Becker W, Guo S, Unterman TG, &, Cohen P, (2001) The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem J 355, 597-607.
86. von Groote-Bidlingmaier F, Schmoll D, Orth HM, Joost HG, Becker W, &, Barthel A, (2003) DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression. Biochem Biophys Res Commun 300, 764-769.
87. Morita K, Lo Celso C, Spencer-Dene B, Zouboulis CC, &, Watt FM, (2006) HAN11 binds mDia1 and controls GLI1 transcriptional activity. J Dermatol Sci 44, 11-20.
88. Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, &, Proud CG, (2001) The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 355, 609-615.
89. Skurat AV, &, Dietrich AD, (2004) Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family protein kinases. J Biol Chem 279, 2490-2498.
90. Kang JE, Choi SA, Park JB, &, Chung KC, (2005) Regulation of the proapoptotic activity of Huntington interacting protein 1 by Dyrk1 and caspase-3 in hippocampal neuroprogenitor cells. J Neurosci Res 81, 62-72.
91. Bescond M, &, Rahmani Z, (2005) Dual-specificity tyrosine- phosphorylated and regulated kinase 1A (DYRK1A) interacts with the phytanoyl-CoA alpha-hydroxylase associated protein 1 (PAHX-AP1), a brain specific protein. Int J Biochem Cell Biol 37, 775-783.
92. Ryu YS, Park SY, Jung MS, Yoon SH, Kwen MY, Lee SY, Choi SH, Radnaabazar C, Kim MK, Kim H, et al. (2010) Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease. J Neurochem 115, 574-584.
93. Aranda S, Alvarez M, Turrõ S, Laguna A, &, de la Luna S, (2008) Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Mol Cell Biol 28, 5899-5911.
94. Matsuo R, Ochiai W, Nakashima K, &, Taga T, (2001) A new expression cloning strategy for isolation of substrate-specific kinases by using phosphorylation site-specific antibody. J Immunol Methods 247, 141-151.
95. Wiechmann S, Czajkowska H, de Graaf K, Grotzinger J, Joost HG, &, Becker W, (2003) Unusual function of the activation loop in the protein kinase DYRK1A. Biochem Biophys Res Commun 302, 403-408.
96. Kim EJ, Sung JY, Lee HJ, Rhim H, Hasegawa M, Iwatsubo T, Min do S, Kim J, Paik SR, &, Chung KC, (2006) Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. J Biol Chem 281, 33250-33257.
97. Ryoo SR, Jeong HK, Radnaabazar C, Yoo JJ, Cho HJ, Lee HW, Kim IS, Cheon YH, Ahn YS, Chung SH, et al. (2007) DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J Biol Chem 282, 34850-34857.
98. Kim D, Won J, Shin DW, Kang J, Kim YJ, Choi SY, Hwang MK, Jeong BW, Kim GS, Joe CO, et al. (2004) Regulation of Dyrk1A kinase activity by 14-3-3. Biochem Biophys Res Commun 323, 499-504.
99. Alvarez M, Altafaj X, Aranda S, &, de la Luna S, (2007) DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding. Mol Biol Cell 18, 1167-1178.